These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 3940646

  • 21. Isolation and characterization of propagable cell lines (HUNC) from the androgen-sensitive Dunning R3327H rat prostatic adenocarcinoma.
    Presnell SC, Borchert KM, Glover WJ, Gregory CW, Mohler JL, Smith GJ.
    Carcinogenesis; 1998 Apr; 19(4):585-90. PubMed ID: 9600341
    [Abstract] [Full Text] [Related]

  • 22. Growth inhibition by diethylstilbestrol and relapse of the Noble rat prostatic tumor.
    Wakisaka M, Drury RE, Kadohama N.
    Hinyokika Kiyo; 1988 Jan; 34(1):107-15. PubMed ID: 3376790
    [Abstract] [Full Text] [Related]

  • 23. Isolation and characterization of a cloned cell line R3327H-G8-A1 derived from the dunning R3327H rat adenocarcinoma.
    Sestili MA, Norris JS, Smith RG.
    Cancer Res; 1983 May; 43(5):2167-75. PubMed ID: 6299542
    [Abstract] [Full Text] [Related]

  • 24. Conversion from a paracrine to an autocrine mechanism of androgen-stimulated growth during malignant transformation of prostatic epithelial cells.
    Gao J, Arnold JT, Isaacs JT.
    Cancer Res; 2001 Jul 01; 61(13):5038-44. PubMed ID: 11431338
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. The influence of androgen deprivation therapy on dihydrotestosterone levels in the prostatic tissue of patients with prostate cancer.
    Nishiyama T, Hashimoto Y, Takahashi K.
    Clin Cancer Res; 2004 Nov 01; 10(21):7121-6. PubMed ID: 15534082
    [Abstract] [Full Text] [Related]

  • 30. Inhibitory effects of somatostatin analogue RC-160 and bombesin/gastrin-releasing peptide antagonist RC-3095 on the growth of the androgen-independent Dunning R-3327-AT-1 rat prostate cancer.
    Pinski J, Reile H, Halmos G, Groot K, Schally AV.
    Cancer Res; 1994 Jan 01; 54(1):169-74. PubMed ID: 7903203
    [Abstract] [Full Text] [Related]

  • 31. Inflammation and epithelial alterations in rat prostate: impact of the androgen to oestrogen ratio.
    Yatkin E, Bernoulli J, Talvitie EM, Santti R.
    Int J Androl; 2009 Aug 01; 32(4):399-410. PubMed ID: 19515173
    [Abstract] [Full Text] [Related]

  • 32. Human prostatic inhibin suppresses tumor growth and inhibits clonogenic cell survival of a model prostatic adenocarcinoma, the Dunning R3327G rat tumor.
    Lokeshwar BL, Hurkadli KS, Sheth AR, Block NL.
    Cancer Res; 1993 Oct 15; 53(20):4855-9. PubMed ID: 8402673
    [Abstract] [Full Text] [Related]

  • 33. Prostate-specific antigen (PSA) promoter-driven androgen-inducible expression of sodium iodide symporter in prostate cancer cell lines.
    Spitzweg C, Zhang S, Bergert ER, Castro MR, McIver B, Heufelder AE, Tindall DJ, Young CY, Morris JC.
    Cancer Res; 1999 May 01; 59(9):2136-41. PubMed ID: 10232600
    [Abstract] [Full Text] [Related]

  • 34. Androgen and prostatic stroma.
    Niu YJ, Ma TX, Zhang J, Xu Y, Han RF, Sun G.
    Asian J Androl; 2003 Mar 01; 5(1):19-26. PubMed ID: 12646998
    [Abstract] [Full Text] [Related]

  • 35. A stroma targeted therapy enhances castration effects in a transplantable rat prostate cancer model.
    Johansson A, Jones J, Pietras K, Kilter S, Skytt A, Rudolfsson SH, Bergh A.
    Prostate; 2007 Nov 01; 67(15):1664-76. PubMed ID: 17854058
    [Abstract] [Full Text] [Related]

  • 36. Castration-induced up-regulation of insulin-like growth factor binding protein-5 potentiates insulin-like growth factor-I activity and accelerates progression to androgen independence in prostate cancer models.
    Miyake H, Pollak M, Gleave ME.
    Cancer Res; 2000 Jun 01; 60(11):3058-64. PubMed ID: 10850457
    [Abstract] [Full Text] [Related]

  • 37. Fatty acid synthase: an early molecular marker of progression of prostatic adenocarcinoma to androgen independence.
    Myers RB, Oelschlager DK, Weiss HL, Frost AR, Grizzle WE.
    J Urol; 2001 Mar 01; 165(3):1027-32. PubMed ID: 11176534
    [Abstract] [Full Text] [Related]

  • 38. Antiproliferative and antimetastatic effects of gossypol on Dunning prostate cell-bearing Copenhagen rats.
    Chang CJ, Ghosh PK, Hu YF, Brueggemeier RW, Lin YC.
    Res Commun Chem Pathol Pharmacol; 1993 Mar 01; 79(3):293-312. PubMed ID: 8480076
    [Abstract] [Full Text] [Related]

  • 39. Androgen up-regulates epidermal growth factor receptor expression and binding affinity in PC3 cell lines expressing the human androgen receptor.
    Brass AL, Barnard J, Patai BL, Salvi D, Rukstalis DB.
    Cancer Res; 1995 Jul 15; 55(14):3197-203. PubMed ID: 7606741
    [Abstract] [Full Text] [Related]

  • 40. Prostate adenocarcinoma: effects of castration on in situ androgen uptake by individual cell types.
    Lippert MC, Keefer DA.
    J Urol; 1987 Jan 15; 137(1):140-5. PubMed ID: 3795357
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.